| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8661952 | International Journal of Cardiology | 2018 | 6 Pages |
Abstract
The number of confirmed angioedema events in PARADIGM-HF was low and there was no-marked excess risk of angioedema with sacubitril/valsartan versus enalapril.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Victor Shi, Michele Senni, Hendrik Streefkerk, Vikas Modgill, Wenchun Zhou, Allen Kaplan,